Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Profit After Tax (2021 - 2025)

Senti Biosciences has reported Profit After Tax over the past 5 years, most recently at -$14.4 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 2227.26% year-over-year to -$14.4 million; the TTM value through Dec 2025 reached -$61.4 million, down 16.29%, while the annual FY2025 figure was -$61.4 million, 16.29% down from the prior year.
  • Profit After Tax for Q4 2025 was -$14.4 million at Senti Biosciences, up from -$18.1 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$1178.0 in Q1 2021 and troughed at -$83.4 million in Q4 2023.
  • A 5-year average of -$18.8 million and a median of -$14.3 million in 2025 define the central range for Profit After Tax.
  • Biggest five-year swings in Profit After Tax: tumbled 1002276.91% in 2022 and later soared 99.26% in 2024.
  • Year by year, Profit After Tax stood at -$3.9 million in 2021, then tumbled by 1409.17% to -$58.2 million in 2022, then plummeted by 43.28% to -$83.4 million in 2023, then soared by 99.26% to -$620000.0 in 2024, then crashed by 2227.26% to -$14.4 million in 2025.
  • Business Quant data shows Profit After Tax for SNTI at -$14.4 million in Q4 2025, -$18.1 million in Q3 2025, and -$14.7 million in Q2 2025.